The FDA is allowing Sarepta to resume shipments of Elevidys (delandistrogene moxeparvovec) to ambulatory patients with Duchenne muscular dystrophy.

Obinutuzumab, a B-cell depleting therapy, is being explored for reducing lupus nephritis risks, such as flare.

The Mediterranean, AHEI, and DASH dietary patterns were linked to reduced risk of type 2 diabetes across ethnic groups.

Maria J. Monroy-Iglesias, Ph.D., from King’s College London, and colleagues used data from the U.K. biobank (151,543 individuals with at least one serum vitamin D level measurement at baseline, 2006 ...

HealthDay News — Women with multiple sclerosis (MS) are less likely to receive disease-modifying therapies (DMTs) than men, according to a study published online July 30 in Neurology.

Children with higher polygenic scores showed accelerated body mass index gain from age 2.5 years to adolescence.